Logo image
Sign in
Targeting triple-negative breast cancer and high-grade ovarian carcinoma: refining BRCAness beyond BRCA1/2 mutations?
Journal article   Peer reviewed

Targeting triple-negative breast cancer and high-grade ovarian carcinoma: refining BRCAness beyond BRCA1/2 mutations?

William Jacot, Charles Theillet, Séverine Guiu and Pierre-Jean Lamy
Future Oncology, Vol.11(4), pp.557-559
02/2015
PMID: 25686112

Abstract

53BP1 BRCA1 breast cancer methylation ovarian cancer targeted therapies
url
Find in HALView

Metrics

1 Record Views

Details

Logo image